BTIG analyst Mark Massaro raised the firm’s price target on Natera (NTRA) to $190 from $185 and keeps a Buy rating on the shares. The company delivered another excellent year, growing revenue by 57% Y/Y in 2024, majorly improving its gross margins, and crossing over to become a cash-generating business, the analyst tells investors in a research note. Natera’s market-leading Signatera MRD test is still only hovering in the low-single digits of market penetration, the firm adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTRA:
- Natera price target raised to $195 from $180 at Canaccord
- Natera’s Strong Growth Potential: Buy Rating Affirmed Amidst Robust Sales Guidance and Product Performance
- Natera Inc. Reports Strong Revenue Growth in 2024
- Natera reports Q4 EPS (41c), consensus (35c)
- Natera sees FY25 revenue $1.87B-$1.95B, consensus $1.81B